**Upcoming Treatment Option for Graves’ Disease Shows Promise** Graves’ disease, an autoimmune disorder that primarily affects the thyroid gland, has...

**How Generative AI is Transforming the Landscape of Clinical Trials** The advent of artificial intelligence (AI) has revolutionized numerous industries,...

**The Impact of Excessive Data: Evaluating Its Benefits and Challenges** In the digital age, data has become the lifeblood of...

**Adapting to Evolving Trends in Clinical Trials: A Catalyst for Innovation** Clinical trials are the cornerstone of medical advancements, providing...

**Phase III Clinical Trial Results Indicate Susvimo’s Potential Effectiveness in Treating Two Diabetic Eye Conditions** In a significant advancement for...

### Increased Risk of Dementia Linked to Traffic-Related Air Pollution #### Introduction Dementia, a debilitating condition characterized by a decline...

**Researchers Discover Speech Patterns Indicative of Future Cognitive Decline** In a groundbreaking study, researchers have identified specific speech patterns that...

**Researchers Discover Speech Pattern Linked to Early Cognitive Decline** In a groundbreaking study, researchers have identified specific speech patterns that...

**FDA Approves Investigational New Drug Application for Muscular Dystrophy Treatment** In a significant stride towards combating muscular dystrophy, the U.S....

**Addressing Obstacles in Conducting Critical Care Trials Amid the COVID-19 Pandemic** The COVID-19 pandemic has posed unprecedented challenges to global...

**Alert for Sites and Sponsors: Fake Job Applicants Could Pass Background Checks – ACRP** In an era where the digital...

**FDA Approves IND for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor, Enabling Phase I Clinical Trial** In a...

**Pharmaceutical Industry’s Perspectives on Artificial Intelligence Unveiled** The pharmaceutical industry, a cornerstone of modern healthcare, is undergoing a transformative shift...

# Utilizing eCOA Technologies to Enhance Patient-Centric Approaches in Healthcare In the rapidly evolving landscape of healthcare, patient-centric approaches have...

# Enhancing Clinical Research Results through Pharmacokinetics (PK) Clinical research is the backbone of medical advancements, providing the necessary data...

**Industry Experts Analyze the Effects of FDA’s Diversity Action Plan** In recent years, the U.S. Food and Drug Administration (FDA)...

**First Patient Receives Descartes-08 in Phase 2 Clinical Trial for Systemic Lupus Erythematosus** In a significant milestone for the treatment...

**First Patient Receives Descartes-08 in Phase 2 Clinical Trial for Systemic Lupus Erythematosus, Reports Drugs.com MedNews** In a significant milestone...

**National Institutes of Health Launches Phase I Trial to Evaluate Safety of Experimental Nasal COVID-19 Vaccine** In a significant stride...

**Guidelines for Safely Alleviating Your Baby’s Teething Pain** Teething is a significant milestone in your baby’s development, but it can...

**Comprehensive Guide to Hot Flashes: Causes, Symptoms, and Latest Research Insights – Seattle Clinical Research Center** Hot flashes are a...

**Comprehensive Guide to Hot Flashes: Causes, Symptoms, and Latest Research – Seattle Clinical Research Center** Hot flashes are a common...

**Key Factors to Consider When Integrating Artificial Intelligence** Artificial Intelligence (AI) has rapidly evolved from a futuristic concept to a...

### Five Clinical Research Studies Available for Men in Florida Clinical research studies are essential for advancing medical knowledge and...

**Promising New Small Molecule Treatment for Obesity Discovered** In recent years, the global obesity epidemic has emerged as a significant...

# Developing a Comprehensive Patient Experience Model to Enhance Medication Design and Interpretation In the rapidly evolving landscape of healthcare,...

**Rybrevant and Leclaza Demonstrate Superior Progression-Free Survival Compared to Tagrisso in Treating EGFR-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC)** In...

**Rybrevant and Leclaza Demonstrate Superior Progression-Free Survival Compared to Tagrisso in Treating EGFR-Mutated Advanced NSCLC** In the ever-evolving landscape of...

**Supreme Court Denies Approval of Purdue Pharma Opioid Settlement** In a landmark decision, the Supreme Court has denied approval of...

**Introducing Antidote Pulse™: Enhancing Recruitment with Real-Time Reporting** In the fast-paced world of recruitment, staying ahead of the curve is...

Promising Non-Medication Approach for Childhood ADHD: Brain Zap Therapy Demonstrates Effectiveness – Drugs.com MedNews

Promising Non-Medication Approach for Childhood ADHD: Brain Zap Therapy Demonstrates Effectiveness

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects millions of children worldwide. Traditionally, medication has been the primary treatment option for managing the symptoms of ADHD. However, recent research has shown promising results for a non-medication approach called brain zap therapy, also known as transcranial direct current stimulation (tDCS).

ADHD is characterized by symptoms such as inattention, hyperactivity, and impulsivity, which can significantly impact a child’s academic performance, social interactions, and overall quality of life. While medications like stimulants and non-stimulants have proven to be effective in reducing these symptoms, they often come with side effects and may not be suitable for all children.

Brain zap therapy involves the application of a weak electrical current to specific areas of the brain using electrodes placed on the scalp. This technique aims to modulate the activity of the brain regions associated with ADHD symptoms, ultimately improving attention, impulse control, and executive functions.

A recent study published in the Journal of Child Psychology and Psychiatry examined the effectiveness of brain zap therapy in children with ADHD. The researchers conducted a randomized controlled trial involving 54 children aged 8 to 12 years who were diagnosed with ADHD. Half of the participants received active brain zap therapy, while the other half received a placebo treatment.

The results of the study showed that children who received active brain zap therapy demonstrated significant improvements in their ADHD symptoms compared to those who received the placebo treatment. The improvements were observed in various domains, including attention, hyperactivity, and impulsivity. Furthermore, these positive effects were maintained even after four weeks of follow-up.

One of the advantages of brain zap therapy is its non-invasive nature. Unlike medication, which may have side effects such as appetite suppression or sleep disturbances, brain zap therapy has been reported to have minimal side effects. The most common side effect reported in studies is a mild tingling sensation or itching at the site of electrode placement, which is generally well-tolerated by children.

Another benefit of brain zap therapy is its potential for long-term effects. While medication provides immediate relief of symptoms, its effects wear off once the medication is discontinued. In contrast, brain zap therapy has shown promise in producing lasting improvements in ADHD symptoms, even after the treatment period ends.

It is important to note that brain zap therapy is still considered an experimental treatment for ADHD, and further research is needed to establish its efficacy and safety. However, the initial findings are encouraging and suggest that this non-medication approach could be a viable alternative or adjunct to traditional ADHD treatments.

Parents and caregivers of children with ADHD should consult with healthcare professionals before considering brain zap therapy. A thorough evaluation of the child’s symptoms, medical history, and individual needs is crucial in determining the most appropriate treatment approach.

In conclusion, brain zap therapy, or transcranial direct current stimulation, shows promise as a non-medication approach for managing childhood ADHD. The initial research suggests that it can effectively reduce ADHD symptoms, with minimal side effects and potential for long-term benefits. As further studies are conducted, brain zap therapy may become a valuable addition to the treatment options available for children with ADHD, providing an alternative for those who cannot tolerate or prefer not to use medication.